The noble gas argon modifies extracellular signal-regulated kinase 1/2 signaling in neurons and glial cells

Eur J Pharmacol. 2012 Jan 15;674(2-3):104-11. doi: 10.1016/j.ejphar.2011.10.045. Epub 2011 Nov 7.

Abstract

Recently, the noble gas argon has been identified as a potent neuroprotective agent, but little is known about its cellular effects. In this in vitro study, we investigated argon's influence on the extracellular signal-regulated kinase (ERK) 1/2, a ubiquitous enzyme with numerous functions in cell proliferation and survival. Primary neuronal and astroglial cell cultures and the microglial cell line BV-2 were exposed to 50 vol.% argon. Further possible effects were studied following stimulation of microglia with 50 ng/ml LPS. ERK 1/2 activation was assessed by phosphorylation state-specific western blotting, cytokine levels by real-time PCR and western blotting. Total phosphotyrosine phosphatase activity was examined with p-nitrophenylphosphate. After 30 min exposure, argon significantly activated ERK 1/2 signaling in microglia. Enhanced phosphorylation of ERK 1/2 was also found in astrocytes and neurons following argon exposure, but it lacked statistical significance. In microglia, argon did not substantially interfere with LPS-induced ERK1/2 activation and inflammatory cytokine induction. Addition of the MEK-Inhibitor U0126 abolished the induced ERK 1/2 phosphorylation. Cellular phosphatase activity and the inactivation of phosphorylated ERK 1/2 were not altered by argon. In conclusion, argon enhanced ERK 1/2 activity in microglia via the upstream kinase MEK, probably through a direct mode of activation. ERK 1/2 signaling in astrocytes and neurons in vitro was also influenced, although not with statistical significance. Whether ERK 1/2 activation by argon affects cellular functions like differentiation and survival in the brain in vivo will have to be determined in future experiments.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Argon / pharmacology*
  • Astrocytes / cytology
  • Astrocytes / drug effects
  • Astrocytes / enzymology
  • Astrocytes / metabolism
  • Cell Line
  • Cytokines / genetics
  • Gene Expression Regulation / drug effects
  • Lipopolysaccharides / pharmacology
  • MAP Kinase Kinase 1 / metabolism
  • MAP Kinase Kinase 2 / metabolism
  • Mice
  • Microglia / cytology
  • Microglia / drug effects
  • Microglia / enzymology
  • Microglia / metabolism
  • Mitogen-Activated Protein Kinase 1 / metabolism*
  • Mitogen-Activated Protein Kinase 3 / metabolism*
  • Neuroglia / cytology
  • Neuroglia / drug effects*
  • Neuroglia / enzymology
  • Neuroglia / metabolism
  • Neurons / cytology
  • Neurons / drug effects*
  • Neurons / enzymology
  • Neurons / metabolism
  • Neuroprotective Agents / pharmacology*
  • Phosphorylation / drug effects
  • Signal Transduction / drug effects*

Substances

  • Cytokines
  • Lipopolysaccharides
  • Neuroprotective Agents
  • Argon
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • MAP Kinase Kinase 1
  • MAP Kinase Kinase 2
  • Map2k2 protein, mouse